| Authors: |
Pauli C; Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland., Bochtler T; Clinical Cooperation Unit Molecular Haematology/Oncology, German Cancer Research Center and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany., Mileshkin L; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia., Baciarello G; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France., Losa F; Medical Oncology Department, Hospital Sant Joan Despí - Moises Broggi, Barcelona, Spain., Ross JS; Pathology Group, Foundation Medicine, Inc, Cambridge, Massachusetts, USA.; Upstate Medical University, Syracuse, New York, USA., Pentheroudakis G; Department of Medical Oncology, University of Ioannina, Ioannina, Greece., Zarkavelis G; Department of Medical Oncology, University of Ioannina, Ioannina, Greece., Yalcin S; Department of Medical Oncology, Hacettepe University, Ankara, Turkey., Özgüroğlu M; Department of Internal Medicine, Division of Medical Oncology, Clinical Trial Unit, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey., Beringer A; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Scarato J; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Mueller-Ohldach M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Thomas M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Moch H; Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland., Krämer A; Clinical Cooperation Unit Molecular Haematology/Oncology, German Cancer Research Center and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany. |
